APO RESEARCH · REPORT
Chloroquine Phosphate
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Product & engineering
Understand the product.
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Selected research
Market Structure
Global Chloroquine Phosphate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Middle East and Africa is the dominant market in the global Chloroquine Phosphate market in terms of value. Sanofi and Bayer are the two players with the largest sales share, occupying 9.24% and 8.36% of the market share in 2019, respectively. And It is worth of noticing that chloroquine phosphate used in COVID-2019 will occupy 24.58% of the market share in 2020.
This report provides an overview of the global Chloroquine Phosphate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Chloroquine Phosphate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Chloroquine Phosphate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chloroquine Phosphate market size, projected growth trends, production technologies, key applications, and end-use industries.
Chloroquine Phosphate Segment by Company
Sanofi
Bayer
Ipca Laboratories
Cipla
Teva Pharmaceuticals
Merck
AstraZeneca
Pharco Pharmaceuticals
Indofarma
Jayson Pharmaceuticals
AM-Europharma
Humax Pharmaceutical
Atlantic Pharmaceutical
Ace Pharmaceuticals BV
Chloroquine Phosphate Segment by Type
Chloroquine Phosphate Injectable
Chloroquine Phosphate Oral
Chloroquine Phosphate Segment by Application
Malaria
COVID-19
Others
Chloroquine Phosphate Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chloroquine Phosphate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chloroquine Phosphate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chloroquine Phosphate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Chloroquine Phosphate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chloroquine Phosphate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chloroquine Phosphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Chloroquine Phosphate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Chloroquine Phosphate Injectable
- Chloroquine Phosphate Oral
Applications
- Malaria
- COVID-19
- Others
Companies covered
- Sanofi
- Bayer
- Ipca Laboratories
- Cipla
- Teva Pharmaceuticals
- Merck
- AstraZeneca
- Pharco Pharmaceuticals
- Indofarma
- Jayson Pharmaceuticals
- AM-Europharma
- Humax Pharmaceutical
- Atlantic Pharmaceutical
- Ace Pharmaceuticals BV
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Chloroquine Phosphate Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Chloroquine Phosphate Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Chloroquine Phosphate Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Chloroquine Phosphate Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Chloroquine Phosphate Market Dynamics
- 2.1 Chloroquine Phosphate Industry Trends
- 2.2 Chloroquine Phosphate Industry Drivers
- 2.3 Chloroquine Phosphate Industry Opportunities and Challenges
- 2.4 Chloroquine Phosphate Industry Restraints
3 Chloroquine Phosphate Market by Manufacturers
- 3.1 Global Chloroquine Phosphate Revenue by Manufacturers (2021-2026)
- 3.2 Global Chloroquine Phosphate Sales by Manufacturers (2021-2026)
- 3.3 Global Chloroquine Phosphate Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Chloroquine Phosphate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Chloroquine Phosphate Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Chloroquine Phosphate Manufacturers, Product Type & Application
- 3.7 Global Chloroquine Phosphate Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Chloroquine Phosphate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Chloroquine Phosphate Players Market Share by Revenue in 2025
- 3.8.3 2025 Chloroquine Phosphate Tier 1, Tier 2, and Tier 3
4 Chloroquine Phosphate Market by Type
- 4.1 Chloroquine Phosphate Type Introduction
- 4.1.1 Chloroquine Phosphate Injectable
- 4.1.2 Chloroquine Phosphate Oral
- 4.2 Global Chloroquine Phosphate Sales by Type
- 4.2.1 Global Chloroquine Phosphate Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Chloroquine Phosphate Sales by Type (2021-2032)
- 4.2.3 Global Chloroquine Phosphate Sales Market Share by Type (2021-2032)
- 4.3 Global Chloroquine Phosphate Revenue by Type
- 4.3.1 Global Chloroquine Phosphate Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Chloroquine Phosphate Revenue by Type (2021-2032)
- 4.3.3 Global Chloroquine Phosphate Revenue Market Share by Type (2021-2032)
5 Chloroquine Phosphate Market by Application
- 5.1 Chloroquine Phosphate Application Introduction
- 5.1.1 Malaria
- 5.1.2 COVID-19
- 5.1.3 Others
- 5.2 Global Chloroquine Phosphate Sales by Application
- 5.2.1 Global Chloroquine Phosphate Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Chloroquine Phosphate Sales by Application (2021-2032)
- 5.2.3 Global Chloroquine Phosphate Sales Market Share by Application (2021-2032)
- 5.3 Global Chloroquine Phosphate Revenue by Application
- 5.3.1 Global Chloroquine Phosphate Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Chloroquine Phosphate Revenue by Application (2021-2032)
- 5.3.3 Global Chloroquine Phosphate Revenue Market Share by Application (2021-2032)
6 Global Chloroquine Phosphate Sales by Region
- 6.1 Global Chloroquine Phosphate Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Chloroquine Phosphate Sales by Region (2021-2032)
- 6.2.1 Global Chloroquine Phosphate Sales by Region (2021-2026)
- 6.2.2 Global Chloroquine Phosphate Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Chloroquine Phosphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Chloroquine Phosphate Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Chloroquine Phosphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Chloroquine Phosphate Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Chloroquine Phosphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Chloroquine Phosphate Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Chloroquine Phosphate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Chloroquine Phosphate Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Chloroquine Phosphate Revenue by Region
- 7.1 Global Chloroquine Phosphate Revenue by Region
- 7.1.1 Global Chloroquine Phosphate Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Chloroquine Phosphate Revenue by Region (2021-2026)
- 7.1.3 Global Chloroquine Phosphate Revenue by Region (2027-2032)
- 7.1.4 Global Chloroquine Phosphate Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Chloroquine Phosphate Revenue (2021-2032)
- 7.2.2 North America Chloroquine Phosphate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Chloroquine Phosphate Revenue (2021-2032)
- 7.3.2 Europe Chloroquine Phosphate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Chloroquine Phosphate Revenue (2021-2032)
- 7.4.2 Asia-Pacific Chloroquine Phosphate Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Chloroquine Phosphate Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Chloroquine Phosphate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Chloroquine Phosphate Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Bayer
- 8.2.1 Bayer Company Information
- 8.2.2 Bayer Business Overview
- 8.2.3 Bayer Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Bayer Chloroquine Phosphate Product Portfolio
- 8.2.5 Bayer Recent Developments
- 8.3 Ipca Laboratories
- 8.3.1 Ipca Laboratories Company Information
- 8.3.2 Ipca Laboratories Business Overview
- 8.3.3 Ipca Laboratories Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Ipca Laboratories Chloroquine Phosphate Product Portfolio
- 8.3.5 Ipca Laboratories Recent Developments
- 8.4 Cipla
- 8.4.1 Cipla Company Information
- 8.4.2 Cipla Business Overview
- 8.4.3 Cipla Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Cipla Chloroquine Phosphate Product Portfolio
- 8.4.5 Cipla Recent Developments
- 8.5 Teva Pharmaceuticals
- 8.5.1 Teva Pharmaceuticals Company Information
- 8.5.2 Teva Pharmaceuticals Business Overview
- 8.5.3 Teva Pharmaceuticals Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Teva Pharmaceuticals Chloroquine Phosphate Product Portfolio
- 8.5.5 Teva Pharmaceuticals Recent Developments
- 8.6 Merck
- 8.6.1 Merck Company Information
- 8.6.2 Merck Business Overview
- 8.6.3 Merck Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Merck Chloroquine Phosphate Product Portfolio
- 8.6.5 Merck Recent Developments
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca Company Information
- 8.7.2 AstraZeneca Business Overview
- 8.7.3 AstraZeneca Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 AstraZeneca Chloroquine Phosphate Product Portfolio
- 8.7.5 AstraZeneca Recent Developments
- 8.8 Pharco Pharmaceuticals
- 8.8.1 Pharco Pharmaceuticals Company Information
- 8.8.2 Pharco Pharmaceuticals Business Overview
- 8.8.3 Pharco Pharmaceuticals Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Pharco Pharmaceuticals Chloroquine Phosphate Product Portfolio
- 8.8.5 Pharco Pharmaceuticals Recent Developments
- 8.9 Indofarma
- 8.9.1 Indofarma Company Information
- 8.9.2 Indofarma Business Overview
- 8.9.3 Indofarma Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Indofarma Chloroquine Phosphate Product Portfolio
- 8.9.5 Indofarma Recent Developments
- 8.10 Jayson Pharmaceuticals
- 8.10.1 Jayson Pharmaceuticals Company Information
- 8.10.2 Jayson Pharmaceuticals Business Overview
- 8.10.3 Jayson Pharmaceuticals Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Jayson Pharmaceuticals Chloroquine Phosphate Product Portfolio
- 8.10.5 Jayson Pharmaceuticals Recent Developments
- 8.11 AM-Europharma
- 8.11.1 AM-Europharma Company Information
- 8.11.2 AM-Europharma Business Overview
- 8.11.3 AM-Europharma Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 AM-Europharma Chloroquine Phosphate Product Portfolio
- 8.11.5 AM-Europharma Recent Developments
- 8.12 Humax Pharmaceutical
- 8.12.1 Humax Pharmaceutical Company Information
- 8.12.2 Humax Pharmaceutical Business Overview
- 8.12.3 Humax Pharmaceutical Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Humax Pharmaceutical Chloroquine Phosphate Product Portfolio
- 8.12.5 Humax Pharmaceutical Recent Developments
- 8.13 Atlantic Pharmaceutical
- 8.13.1 Atlantic Pharmaceutical Company Information
- 8.13.2 Atlantic Pharmaceutical Business Overview
- 8.13.3 Atlantic Pharmaceutical Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Atlantic Pharmaceutical Chloroquine Phosphate Product Portfolio
- 8.13.5 Atlantic Pharmaceutical Recent Developments
- 8.14 Ace Pharmaceuticals BV
- 8.14.1 Ace Pharmaceuticals BV Company Information
- 8.14.2 Ace Pharmaceuticals BV Business Overview
- 8.14.3 Ace Pharmaceuticals BV Chloroquine Phosphate Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Ace Pharmaceuticals BV Chloroquine Phosphate Product Portfolio
- 8.14.5 Ace Pharmaceuticals BV Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Chloroquine Phosphate Value Chain Analysis
- 9.1.1 Chloroquine Phosphate Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Chloroquine Phosphate Production Mode & Process
- 9.2 Chloroquine Phosphate Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Chloroquine Phosphate Distributors
- 9.2.3 Chloroquine Phosphate Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst